Procter & Gamble Health Limited has fixed August 21, 2026 as the record date for its 59th Annual General Meeting and dividend payment. The company announced that the Annual General Meeting is scheduled to be held on August 27, 2026. Shareholders registered on the record date will be eligible to participate in the meeting and receive the dividend, subject to approval by the members at the ensuing Annual General Meeting.

The disclosure was submitted to the stock exchanges by Zeal Bhavin Rupani, Company Secretary of Procter & Gamble Health Limited. The notification was addressed to The BSE Limited and The National Stock Exchange of India Limited to ensure compliance with regulatory requirements.

Key Details

The dividend payment is contingent upon approval by the shareholders during the Annual General Meeting. Procter & Gamble Health Limited has its registered office at P&G Plaza, Cardinal Gracias Road, Chakala, Andheri-E, Mumbai.

Procter & Gamble Health Limited has announced the successful sale of immovable properties in Mumbai, generating a substantial profit for the healthcare company. The transaction was completed on April 30, 2026, marking a significant asset disposal for the organization.

Transaction Details

The company executed an indenture of sale for the disposal of certain immovable properties situated in Mumbai on April 30, 2026. This strategic move is expected to contribute positively to the company's financial performance.

Regulatory Compliance

Procter & Gamble Health Limited has fulfilled its regulatory obligations by informing both major stock exchanges about this material transaction. The company submitted the required intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to:

• BSE Limited (Scrip Code: 500126)
• National Stock Exchange of India Limited (Scrip Code: PGHL)

Financial Impact

The property sale is projected to generate approximately ₹32 crores in profit for Procter & Gamble Health Limited. This significant gain from the disposal of real estate assets demonstrates the company's ability to optimize its asset portfolio and generate value from non-core holdings.

Corporate Authorization

The regulatory filing was digitally signed by Zeal Rupani, Company Secretary of Procter & Gamble Health Limited, on April 30, 2026, at 22:41:29 +05'30'. The formal communication ensures transparency and compliance with stock exchange requirements for material events that could impact investor decisions.